Search Browse Earnings

Coya Therapeutics, Inc. — SlamSEC

Coya Therapeutics, Inc.

Nasdaq:COYA

Pharmaceutical Preparations·HOUSTON, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$6.0M

FY 2024

Adj. EBITDA

-$7.9M

-131.2% margin

FY 2024

Net Income

-$8.0M

-133.1% margin

FY 2024

EPS (Diluted)

-$0.79

FY 2024

Stock Price

$4.91

+1.3%

2026-03-10

52W Range

$3.94 – $7.75

P/E Ratio

-6.2x

Market Cap

$102.7M

Cash

$32.6M

FY 2024

Total Debt

—

Net Cash

$32.6M

FY 2024

Enterprise Value

$70.1M

Debt / EBITDA

4.1x

FY 2024

EV / EBITDA

-8.9x

Employees

—